Long COVID might be a bigger problem than researchers thought
Long COVID may be affecting people who were asymptomatic during their infections at a higher rate than researchers expected, a new study conducted by the nonprofit FAIR Health suggests, The New York Times reports.
The study analyzed the health insurance records of 2 million people diagnosed with COVID-19 and found that 23 percent of them later sought medical treatment for new conditions. Among the overall group, rates were highest for people who had dealt with serious bouts of the disease, but even 19 percent of the people who were asymptomatic experienced subsequent medical issues, a figure that surprised FAIR Health's research team, the organization's president Robin Gelburd told the Times.
The study deserves praise for its size and "ability to look across the range of disease severity in a diversity of age groups," said Dr. Helen Chu, a professor of medicine and infectious disease at the University of Washington School of Medicine. At the same time, like most studies, it doesn't paint a complete a picture. Per the Times, it's possible that some of the asymptomatic patients later developed symptoms after their diagnosis, and the study also doesn't compare people who had COVID-19 with those who didn't, so it's not clear whether the medical treatment rates are similar. On the latter point, though, smaller studies have suggested that previously infected patients do, in fact, require treatment more often. Read more at The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The best new music of 2024 by genre
The Week Recommends Outstanding albums, from pop to electro and classical
By The Week UK Published
-
Nine best TV shows of 2024 to binge this Christmas
The Week Recommends From Baby Reindeer and Slow Horses to Rivals and Shogun, here are the critics' favourites
By The Week UK Published
-
Crossword: December 28, 2024
The Week's daily crossword puzzle
By The Week Staff Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published